Advanced

Cervical cytology biobanking in Europe

Arbyn, Marc; Van Veen, Evert-Ben; Andersson, Kristin LU ; Bogers, Johannes; Boulet, Gaelle; Bergeron, Christine; von Knebel-Doeberitz, Magnus and Dillner, Joakim LU (2010) In International Journal of Biological Markers 25(3). p.117-125
Abstract
A cervical cytology biobank (CCB) is an extension of current cytopathology laboratory practice consisting in the systematic storage of Pap smears or liquid-based cytology samples from women participating in cervical cancer screening with the explicit purpose to facilitate future scientific research and quality audit of preventive services. A CCB should use an internationally agreed uniform cytology terminology, be integrated in a national or regional screening registry, and be linked to other registries (histology, cancer, vaccination). Legal and ethical principles concerning personal integrity and data safety must be respected strictly. Biobank-based studies require approval of ethical review boards. A CCB is an almost inexhaustible... (More)
A cervical cytology biobank (CCB) is an extension of current cytopathology laboratory practice consisting in the systematic storage of Pap smears or liquid-based cytology samples from women participating in cervical cancer screening with the explicit purpose to facilitate future scientific research and quality audit of preventive services. A CCB should use an internationally agreed uniform cytology terminology, be integrated in a national or regional screening registry, and be linked to other registries (histology, cancer, vaccination). Legal and ethical principles concerning personal integrity and data safety must be respected strictly. Biobank-based studies require approval of ethical review boards. A CCB is an almost inexhaustible resource for fundamental and applied biological research. In particular, it can contribute to answering questions on the natural history of HPV infection and HPV-induced lesions and cancers, screening effectiveness, exploration of new biomarkers, and surveillance of the short- and long-term effects of the introduction of HPV vaccination. To understand the limitations of CCB, more studies are needed on the quality of samples in relation to sample type, storage procedures, and duration of storage. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
papillomavirus, Human, Molecular markers, Biobank, Cervical cancer, Cervical cytology
in
International Journal of Biological Markers
volume
25
issue
3
pages
117 - 125
publisher
Wichtig Editore
external identifiers
  • wos:000284394000001
  • scopus:78650846473
ISSN
0393-6155
language
English
LU publication?
yes
id
30d8ed34-cb51-4d9b-88e3-226d246e925a (old id 1752464)
date added to LUP
2011-01-04 07:35:59
date last changed
2018-05-13 03:00:24
@article{30d8ed34-cb51-4d9b-88e3-226d246e925a,
  abstract     = {A cervical cytology biobank (CCB) is an extension of current cytopathology laboratory practice consisting in the systematic storage of Pap smears or liquid-based cytology samples from women participating in cervical cancer screening with the explicit purpose to facilitate future scientific research and quality audit of preventive services. A CCB should use an internationally agreed uniform cytology terminology, be integrated in a national or regional screening registry, and be linked to other registries (histology, cancer, vaccination). Legal and ethical principles concerning personal integrity and data safety must be respected strictly. Biobank-based studies require approval of ethical review boards. A CCB is an almost inexhaustible resource for fundamental and applied biological research. In particular, it can contribute to answering questions on the natural history of HPV infection and HPV-induced lesions and cancers, screening effectiveness, exploration of new biomarkers, and surveillance of the short- and long-term effects of the introduction of HPV vaccination. To understand the limitations of CCB, more studies are needed on the quality of samples in relation to sample type, storage procedures, and duration of storage.},
  author       = {Arbyn, Marc and Van Veen, Evert-Ben and Andersson, Kristin and Bogers, Johannes and Boulet, Gaelle and Bergeron, Christine and von Knebel-Doeberitz, Magnus and Dillner, Joakim},
  issn         = {0393-6155},
  keyword      = {papillomavirus,Human,Molecular markers,Biobank,Cervical cancer,Cervical cytology},
  language     = {eng},
  number       = {3},
  pages        = {117--125},
  publisher    = {Wichtig Editore},
  series       = {International Journal of Biological Markers},
  title        = {Cervical cytology biobanking in Europe},
  volume       = {25},
  year         = {2010},
}